BDTB Bodhi Tree Biotechnology Inc.

Fundamentals / CIK 0002041531 / USD

Bodhi Tree Biotechnology Inc. reported $37K in revenue and a net loss of $116K for the trailing twelve months ended June 30, 2026, with a -310.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BDTB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Sep 30
Revenue $17K
Operating Income -$148K
Income Before Tax -$148K
Income Tax Expense $2.0K
Net Income -$150K
Basic EPS -$0.01
Diluted EPS -$0.01
Basic Shares Outstanding 25.4M
Diluted Shares Outstanding 25.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue $10K $15K $0 $12K $0 $0 $5.0K --
Operating Income -$23K -$28K -$53K -$11K -$20K -$52K -$65K -$72K
Income Before Tax -$23K -$28K -$53K -$11K -$20K -$52K -$65K --
Income Tax Expense -- $1.3K -- -- $800 $1.2K -- --
Net Income -$23K -$29K -$53K -$11K -$21K -$53K -$65K -$72K
Basic EPS $0.00 $0.00 -$0.01 -- $0.00 $0.00 $0.00 --
Diluted EPS $0.00 $0.00 -$0.01 -- $0.00 $0.00 $0.00 --
Basic Shares Outstanding 25.4M 25.4M 25.4M -- 25.4M 25.4M 25.4M --
Diluted Shares Outstanding 25.4M 25.4M 25.4M -- 25.4M 25.4M 25.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Sep 30 Sep 30
Cash & Cash Equivalents $109K $260K
Cash & Short-Term Investments $109K $260K
Total Assets $119K $269K
Total Current Liabilities -- $500
Total Non-Current Liabilities -- $0
Total Liabilities $0 $500
Common Stock $2.5K $2.5K
Retained Earnings -$212K -$62K
Total Stockholders' Equity $119K $269K
Total Equity $119K $269K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Cash & Cash Equivalents $4.0K $23K $47K $109K $120K $144K $260K
Cash & Short-Term Investments $4.0K $23K $47K $109K $120K $144K $260K
Total Assets $18K $41K $70K $119K $130K $151K $269K
Total Current Liabilities $4.5K $3.5K $3.5K -- -- -- $500
Total Non-Current Liabilities $0 $0 $0 -- -- -- $0
Total Liabilities $4.5K $3.5K $3.5K $0 $0 $0 $500
Common Stock $2.5K $2.5K $2.5K $2.5K $2.5K $2.5K $2.5K
Retained Earnings -$317K -$294K -$265K -$212K -$201K -$180K -$62K
Total Stockholders' Equity $14K $37K $66K $119K $130K $151K $269K
Total Equity $14K $37K $66K $119K $130K $151K $269K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Sep 30
Net Income -$150K
Operating Cash Flow -$150K
Net Change in Cash -$150K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$23K -$29K -$53K -$11K -$21K -$53K -$65K -$72K
Operating Cash Flow -$19K -$25K -$62K -$10K -$25K -$50K -$65K -$91K
Financing Cash Flow -- -- -- -- -- -- -- $281K
Net Change in Cash -$19K -$25K -$62K -$10K -$25K -$50K -$65K $190K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Sep 30
Operating Margin -868.3%
Net Profit Margin -880.4%
Return on Equity (ROE) -125.6%
Return on Assets (ROA) -125.6%

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Operating Margin -310.2% -413.1% -1131.6% -868.3% -- -- -- --
Net Profit Margin -313.6% -420.8% -1148.6% -880.4% -- -- -- --
Return on Equity (ROE) -839.4% -306.9% -208.2% -125.6% -162.1% -119.5% -- --
Return on Assets (ROA) -633.2% -280.4% -197.7% -125.6% -162.1% -119.5% -- --
Quick Ratio 0.89x 6.50x 13.53x -- -- -- -- 519.14x
Revenue Growth (YoY) -- -- -100.0% -- -100.0% -- -- --
Operating Income Growth (YoY) -- -- -- -- -305.3% -- -- --
Net Income Growth (YoY) -- -- -- -- -313.5% -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -227.1% -13154.2% -- --
Source: SEC EDGAR CompanyFacts (CIK 0002041531) · from March 31, 2024 Data through June 30, 2026 · synced Nov 21, 2026, 05:09 UTC · Open in terminal